Pharmacist by training (PharmD) and holder of a Master’s degree in Regulatory Affairs, I have over 25 years of experience in regulatory affairs, with a strong focus on global strategy and product development. I am currently Director of Regulatory Affairs and Quality Assurance at Vivet Therapeutics, a biotechnology company dedicated to developing gene therapies for metabolic disorders.

I began my career at Pfizer and then Baxter, where I worked on global development, registration, and life cycle management of renal drug portfolios. Over the years, I have specialized in regulatory strategy and the development of biologics and advanced therapies for rare diseases. My experience includes key roles at LFB (a global player in plasma-derived products and recombinant therapeutic proteins), Onxeo where I worked on oncology products, Gensight Biologics (focused on gene therapies for ophthalmologic diseases), and Vivet Therapeutics.